PRESIDENT Raúl Castro Ruz received
on September 27 President Taur Matan Ruak of the
Democratic Republic of Timor-Leste, during the
latter’s official visit to Cuba.
the official reception ceremony, the two leaders
reviewed the excellent state of bilateral relations
and expressed their will to consolidate cooperation,
particularly in the context of health and education.
They also discussed current international issues.
During his stay, the Timor Leste
President and his delegation met with scientists at
the Genetic Engineering and Biotechnology Center (CIGB),
where they were presented with medicines developed
by this institution, such as the recognized
Heberprot-P for the treatment of diabetic foot
ulcers, and the vaccine against Hepatitis B,
included on the 171 registers of 14 products in 57
countries, as the CIGB researchers confirmed.
Timorese Health Minister Sergio Gama
Lobo showed interest in these two Cuban products and
inquired into their application.
The scientists also referred to the
possibility of establishing cooperation between the
institution and the Timor Leste government for the
treatment of foot ulcers, as a way of raising the
quality of life of persons suffering from diabetes.
At the end of his visit to the
Center, President Taur Matan Ruak affirmed that
there are two ways of treating people in the world:
one is preventative and the other curative, and the
better one is that of Cuba; preventative health care.
He subsequently stated that
education and innovation are key to increased
collaboration between the two nations, which he
reiterated before leaving the country, saying that
he is seeking to consolidate relations between Timor
Leste and Cuba, above all in the health and